The estimated value of the global digital pathology market was around USD 725.10 million in 2021 and is expected to reach around USD 1,493.66 million by 2028, with a CAGR of roughly 12.8 percent over the course of the forecast period.
Overview of the Digital Pathology Market:
As advancements in healthcare technology take over the global healthcare infrastructure, digital pathology—which enables laboratories to give test and diagnosis findings online—is becoming increasingly prevalent. The COVID-19 epidemic increased the need for digital pathology because it was acceptable under lockdown and social distance standards. The analysis analyses the drivers, restraints/challenges, and effects on demand of the Digital Pathology market throughout the forecasted period. The report also considers potential business opportunities in the market for digital pathology. Increased technological adoption, rapid advancements in digital pathology, rising demand for high-quality treatment and diagnostics, an increase in the prevalence of fatal diseases, and rising demand for effective laboratory testing are some of the key factors boosting the market potential for digital pathology during the forecast period.
Global Digital Pathology Market Segmentation:
The market for digital pathology is segmented by kinds, product types, applications, end users, and geographical areas.
The market’s product segments are scanners, software, communication systems, and storage systems. Over the projected period, the scanners section is anticipated to be the most profitable. These expensive and necessary devices are large and will continue to be a significant value share in the global digital pathology market over the forecast period.
The Digital Pathology market has four applications: drug discovery, disease diagnostics, teleconsultation, and training and education. During the projected period, the drug discovery segment is likely to have a leading outlook. Through 2028, rising medicine demand and expanded R&D for novel pharmaceuticals are expected to be the main factors driving demand growth in this sector.
Some of the main competitors dominating the global Digital Pathology market include – Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics K.K. (Japan), Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US)
Global Digital Pathology market is segmented as follows:
Training & Education
By End User
Pharmaceutical & Biotechnology Companies
Hospitals and Reference Laboratories
Academic & Research Institutes
Zion Market Research
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL-FREE +1 (855) 465-4651
Email: [email protected]